Maryland’s Department of Health awarded more than $520,000 to 18 groups of fire departments to run multi-cancer early detection (MCED) screening using 20/20 BioLabs’ OneTest blood assay. The grant program will fund testing for more than 1,400 firefighters and is scheduled to run in April or May. The funding increase is reported as 225% versus the prior year’s number of funded OneTest assays. 20/20 BioLabs said it plans to pursue coverage engagement with the U.S. Centers for Medicare and Medicaid Services (CMS) and to use the firefighter dataset as real-world evidence supporting regulatory and reimbursement discussions. OneTest for Cancer combines protein tumor marker measurements with machine-learning-based analysis and is designed to test for more than a dozen cancers. The company also points to a OneTest for Longevity product expected to launch in the first half of 2026. The expansion matters for MCED commercialization because it adds a public-institution pathway for sampling that can strengthen evidence packages around performance and operational feasibility outside academic settings.